Market Cap 642.61M
Revenue (ttm) 0.00
Net Income (ttm) -190.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 7,282,200
Avg Vol 6,568,236
Day's Range N/A - N/A
Shares Out 345.49M
Stochastic %K 2%
Beta 0.47
Analysts Strong Sell
Price Target $8.35

Company Profile

Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases. It develops a pipeline of multiple allogeneic CAR T cell product candidates utilizing protein engineering, gene editing, gene insertion, and advanced proprietary T cell manufacturing technologies. The company is also developing cemacabtagene ansegedleucel (cema-cel), an engineered allogeneic CAR T...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 457 2700
Address:
210 East Grand Avenue, South San Francisco, United States
kafksdsdvsdl
kafksdsdvsdl Sep. 9 at 5:45 PM
$ALLO my buy order at 1.77 did not go though for a whole hour. Just got in at 1.78. Seems pretty firm base at least for today.
1 · Reply
JHisai
JHisai Sep. 9 at 5:39 PM
$ALLO upper trendchannel line in weekly logchart at 1.72, also have a bookmark at 1.64, which would suck ...
0 · Reply
x_pressionist
x_pressionist Sep. 9 at 3:30 PM
$ALLO Next up 1.75.
0 · Reply
AS1980
AS1980 Sep. 9 at 3:27 PM
$ALLO yeah shorts The company said news expected next year Perfect target to short it
0 · Reply
Filvul
Filvul Sep. 9 at 2:40 PM
$ALLO how low can we go? Any thoughts?
2 · Reply
x_pressionist
x_pressionist Sep. 9 at 1:37 PM
$ALLO Do we have 8 reds in a row?
1 · Reply
microdine
microdine Sep. 9 at 12:17 PM
$ALLO nothing new that’s we haven’t already know
0 · Reply
microdine
microdine Sep. 8 at 8:05 PM
$ALLO LETS GET THIS MONEY
0 · Reply
BraSJ
BraSJ Sep. 8 at 6:43 PM
$ALLO could not resist bought another $3K
0 · Reply
Filvul
Filvul Sep. 8 at 6:06 PM
$ALLO damn this stock., is it cursed?
1 · Reply
Latest News on ALLO
Allogene Therapeutics management to meet with Piper Sandler

2026-09-04T19:10:52.000Z - 5 days ago

Allogene Therapeutics management to meet with Piper Sandler


Allogene Therapeutics CFO Geoffrey Parker to retire

2026-09-02T12:45:35.000Z - 8 days ago

Allogene Therapeutics CFO Geoffrey Parker to retire


Allogene Therapeutics files $500M mixed securities shelf

2026-08-17T08:46:29.000Z - 24 days ago

Allogene Therapeutics files $500M mixed securities shelf


Allogene Therapeutics reports Q2 EPS (13c), consensus (15c)

2026-08-17T08:46:00.000Z - 24 days ago

Allogene Therapeutics reports Q2 EPS (13c), consensus (15c)


Allogene Therapeutics Slides: Corporate presentation

Aug 13, 2026, 7:00 AM EDT - 4 weeks ago

Allogene Therapeutics Slides: Corporate presentation


Allogene Therapeutics Earnings Call Transcript: Q2 2026

Aug 12, 2026, 5:00 PM EDT - 4 weeks ago

Allogene Therapeutics Earnings Call Transcript: Q2 2026


Allogene Therapeutics Earnings release: Q2 2026

Aug 12, 2026, 5:00 PM EDT - 4 weeks ago

Allogene Therapeutics Earnings release: Q2 2026


Allogene Therapeutics Quarterly report: Q2 2026

Aug 12, 2026, 5:00 PM EDT - 4 weeks ago

Allogene Therapeutics Quarterly report: Q2 2026


Allogene Therapeutics Transcript: AGM 2026

Jun 18, 2026, 11:00 AM EDT - 2 months ago

Allogene Therapeutics Transcript: AGM 2026


Allogene Therapeutics Announces Planned CEO Succession

May 28, 2026, 5:02 PM EDT - 3 months ago

Allogene Therapeutics Announces Planned CEO Succession


Allogene Therapeutics Proxy statement: Proxy filing

May 28, 2026, 8:00 AM EDT - 3 months ago

Allogene Therapeutics Proxy statement: Proxy filing


Allogene Therapeutics Proxy statement: Proxy filing

May 21, 2026, 8:00 AM EDT - 3 months ago

Allogene Therapeutics Proxy statement: Proxy filing


Allogene Therapeutics Slides: Corporate presentation

May 16, 2026, 7:00 AM EDT - 3 months ago

Allogene Therapeutics Slides: Corporate presentation


Allogene Therapeutics ends China cell therapy deal with Overland

May 13, 2026, 5:05 PM EDT - 3 months ago

Allogene Therapeutics ends China cell therapy deal with Overland


Allogene Therapeutics reports Q1 EPS (18c), consensus (18c)

2026-05-13T21:04:53.000Z - 3 months ago

Allogene Therapeutics reports Q1 EPS (18c), consensus (18c)


Allogene Therapeutics Earnings Call Transcript: Q1 2026

May 13, 2026, 5:00 PM EDT - 3 months ago

Allogene Therapeutics Earnings Call Transcript: Q1 2026


Allogene Therapeutics Earnings release: Q1 2026

May 13, 2026, 5:00 PM EDT - 3 months ago

Allogene Therapeutics Earnings release: Q1 2026


Allogene Therapeutics Quarterly report: Q1 2026

May 13, 2026, 5:00 PM EDT - 3 months ago

Allogene Therapeutics Quarterly report: Q1 2026


Allogene Therapeutics Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

Allogene Therapeutics Proxy statement: Proxy filing


Allogene Therapeutics Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

Allogene Therapeutics Proxy statement: Proxy filing


Allogene Therapeutics Proxy statement: Proxy filing

Apr 20, 2026, 8:00 AM EDT - 4 months ago

Allogene Therapeutics Proxy statement: Proxy filing


Allogene Therapeutics Transcript: Study result

Apr 13, 2026, 8:30 AM EDT - 5 months ago

Allogene Therapeutics Transcript: Study result


Allogene Therapeutics Press release: Study result

Apr 13, 2026, 8:30 AM EDT - 5 months ago

Allogene Therapeutics Press release: Study result


Allogene Therapeutics Slides: Study result

Apr 13, 2026, 8:30 AM EDT - 5 months ago

Allogene Therapeutics Slides: Study result


Allogene Therapeutics Earnings Call Transcript: Q4 2025

Mar 12, 2026, 5:00 PM EDT - 6 months ago

Allogene Therapeutics Earnings Call Transcript: Q4 2025


Allogene Therapeutics Annual report: Q4 2025

Mar 12, 2026, 5:00 PM EDT - 6 months ago

Allogene Therapeutics Annual report: Q4 2025


Allogene Therapeutics Earnings release: Q4 2025

Mar 12, 2026, 5:00 PM EDT - 6 months ago

Allogene Therapeutics Earnings release: Q4 2025


Allogene Therapeutics Slides: Corporate presentation

Mar 12, 2026, 4:00 PM EDT - 6 months ago

Allogene Therapeutics Slides: Corporate presentation


Allogene Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

Allogene Therapeutics Earnings Call Transcript: Q3 2025


Allogene Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

Allogene Therapeutics Quarterly report: Q3 2025


Allogene Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

Allogene Therapeutics Earnings release: Q3 2025


Allogene Therapeutics Transcript: Citi's SMID Call Series 2025

Oct 2, 2025, 1:00 PM EDT - 11 months ago

Allogene Therapeutics Transcript: Citi's SMID Call Series 2025


Allogene Therapeutics Earnings Call Transcript: Q2 2025

Aug 13, 2025, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Earnings Call Transcript: Q2 2025


Allogene Therapeutics Quarterly report: Q2 2025

Aug 13, 2025, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Quarterly report: Q2 2025


Allogene Therapeutics Earnings release: Q2 2025

Aug 13, 2025, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Earnings release: Q2 2025


Allogene Therapeutics Transcript: Study Result

Aug 1, 2025, 11:00 AM EDT - 1 year ago

Allogene Therapeutics Transcript: Study Result


Allogene Therapeutics Press release: Study Result

Aug 1, 2025, 11:00 AM EDT - 1 year ago

Allogene Therapeutics Press release: Study Result


Allogene Therapeutics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

Allogene Therapeutics Slides: Corporate Presentation


Allogene Therapeutics Earnings Call Transcript: Q1 2025

May 13, 2025, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Earnings Call Transcript: Q1 2025


Allogene Therapeutics Quarterly report: Q1 2025

May 13, 2025, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Quarterly report: Q1 2025


Allogene Therapeutics Earnings release: Q1 2025

May 13, 2025, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Earnings release: Q1 2025


Allogene Therapeutics Slides: Corporate Presentation

May 12, 2025, 6:00 PM EDT - 1 year ago

Allogene Therapeutics Slides: Corporate Presentation


Allogene Therapeutics Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Allogene Therapeutics Proxy statement: Proxy Filing


Allogene Therapeutics Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Allogene Therapeutics Proxy statement: Proxy Filing


Allogene Therapeutics Earnings Call Transcript: Q4 2024

Mar 13, 2025, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Earnings Call Transcript: Q4 2024


Allogene Therapeutics Annual report: Q4 2024

Mar 13, 2025, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Annual report: Q4 2024


Allogene Therapeutics Earnings release: Q4 2024

Mar 13, 2025, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Earnings release: Q4 2024


Allogene Therapeutics Slides: FY 2025

Jan 15, 2025, 6:00 PM EST - 1 year ago

Allogene Therapeutics Slides: FY 2025


Allogene Therapeutics Slides: Corporate Presentation

Jan 12, 2025, 6:00 PM EST - 1 year ago

Allogene Therapeutics Slides: Corporate Presentation


Allogene Therapeutics Earnings Call Transcript: Q3 2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

Allogene Therapeutics Earnings Call Transcript: Q3 2024


Allogene Therapeutics Quarterly report: Q3 2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

Allogene Therapeutics Quarterly report: Q3 2024


Allogene Therapeutics Earnings release: Q3 2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

Allogene Therapeutics Earnings release: Q3 2024


kafksdsdvsdl
kafksdsdvsdl Sep. 9 at 5:45 PM
$ALLO my buy order at 1.77 did not go though for a whole hour. Just got in at 1.78. Seems pretty firm base at least for today.
1 · Reply
JHisai
JHisai Sep. 9 at 5:39 PM
$ALLO upper trendchannel line in weekly logchart at 1.72, also have a bookmark at 1.64, which would suck ...
0 · Reply
x_pressionist
x_pressionist Sep. 9 at 3:30 PM
$ALLO Next up 1.75.
0 · Reply
AS1980
AS1980 Sep. 9 at 3:27 PM
$ALLO yeah shorts The company said news expected next year Perfect target to short it
0 · Reply
Filvul
Filvul Sep. 9 at 2:40 PM
$ALLO how low can we go? Any thoughts?
2 · Reply
x_pressionist
x_pressionist Sep. 9 at 1:37 PM
$ALLO Do we have 8 reds in a row?
1 · Reply
microdine
microdine Sep. 9 at 12:17 PM
$ALLO nothing new that’s we haven’t already know
0 · Reply
microdine
microdine Sep. 8 at 8:05 PM
$ALLO LETS GET THIS MONEY
0 · Reply
BraSJ
BraSJ Sep. 8 at 6:43 PM
$ALLO could not resist bought another $3K
0 · Reply
Filvul
Filvul Sep. 8 at 6:06 PM
$ALLO damn this stock., is it cursed?
1 · Reply
BG_BULL
BG_BULL Sep. 8 at 5:58 PM
$ALLO Why does it fall like this today. I don't see bad news. I'm buying 😎
0 · Reply
x_pressionist
x_pressionist Sep. 8 at 1:41 PM
$ALLO Broke through 1.96. Next 1.88!
1 · Reply
x_pressionist
x_pressionist Sep. 4 at 6:33 PM
$ALLO I don’t believe ALLO has had six consecutive red days in the past year. Could today be the first time?
1 · Reply
Unburdened
Unburdened Sep. 2 at 6:24 PM
$ALLO Need to stop watching this stock every day. We know nothing's gonna happen until next year. They seem to be moving ahead with expansion of jobs with a thought of good results next year. In the meantime, we continue to have new shareholders at our expense because of incompetent management and the debacle that was the equity raise.
1 · Reply
thesaltier1
thesaltier1 Sep. 2 at 3:57 PM
$ALLO reason for todays drop is I bought more
1 · Reply
StijnRR
StijnRR Sep. 1 at 7:37 AM
$ALLO — More new Allogene job postings have appeared in recent days, with several focused on manufacturing, process development, analytical science and supply chain. What stands out is that the company is still hiring for PPQ, BLA readiness and commercial pre/post-launch activities, not just early-stage R&D. This suggests management continues to invest heavily in the infrastructure needed to bring its pipeline toward commercialization, which I see as a bullish signal for ALLO-329 and ALPHA3. Of course, jobs don’t guarantee positive data, but continuing to build this organization ahead of major catalysts is certainly encouraging.
5 · Reply
Filvul
Filvul Aug. 31 at 2:25 PM
$ALLO damn...
0 · Reply
Daryl142
Daryl142 Aug. 27 at 7:36 PM
$ALLO oh my. I’ve been holding ALLO for nearly 10 years hoping and praying that this is the cure to end all. Now, I just want them to get bought out already!
1 · Reply
Unburdened
Unburdened Aug. 26 at 5:09 PM
$ALLO Can't this garbage ever put together two winning days in a row?
1 · Reply
DoctrBenway
DoctrBenway Aug. 26 at 3:21 PM
$ALLO I don't think Arie would be here if there wasn't extreme promise. I doubled down today @ 2.07, will triple @ 1.99 should it trip.
2 · Reply
x_pressionist
x_pressionist Aug. 26 at 8:18 AM
$ALLO filed a Form S‑3 shelf on 12 August 2026 (effective 20 August 2026) to sell up to $500 million of stock, preferred shares, debt and warrants over time. This is on top of the $200.4 million equity raise it closed on 16 April 2026 (about 100 million shares at $2 each). The shelf doesn’t mean new shares are being sold right now, but it does leave room for more issuance and potential dilution in the near future. http://archive.fast-edgar.com/20260821/A5ZSRFZZZBQZ6ZZ2Z22QWZZLL7RDZZ2SV2Z2
1 · Reply
Edadi
Edadi Aug. 25 at 9:15 PM
$ALLO the careers openings seem as a positive sign, if we start to see a steady slow climb, might be getting ready for significant release in the ASH congress in December (the most important congress in hematology)
0 · Reply